問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol Number1941-CL-2003

2012-01-01 - 2013-09-30

Phase III

Terminated8

ICD-10E11.9

Type 2 diabetes mellitus without complications

ICD-10E13.9

Other specified diabetes mellitus without complications

ICD-9250.00

Diabetes mellitus without mention of complication, Type II [non-insulin dependent type][NIDDM type] [ adult-onset type] or unspecified type, not stated as uncontrolled

  • Trial Applicant

    Astellas Pharma Inc.

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2025/08/20

Investigators and Locations

Principal Investigator LEE-MING CHUANG Division of General Internal Medicine

Co-Principal Investigator

  • 呂金盈 Division of General Internal Medicine
  • - - Division of General Internal Medicine
  • 李弘元 Division of General Internal Medicine
  • 張恬君 Division of General Internal Medicine

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator 裴馰 Division of Endocrinology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Chen-Ling Huang Division of Endocrinology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator 陳榮福 Division of Endocrinology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Jui-Hung Sun Division of Endocrinology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator 曾士婷 Division of Endocrinology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Ching-Chu Chen Division of Endocrinology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator 洪乙仁 Division of Endocrinology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    500 participants

  • Global

    1500 participants